Vyjuvek is indicated for the treatment of wounds in patients with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene, from birth
MeSH: Epidermolysis Bullosa Dystrophica
Group: Preparations for treatment of wounds and ulcers